[PDF][PDF] Construction of novel vaccines on the basis of the virus-like particles: Hepatitis B virus proteins as vaccine carriers

P Pumpens, R Ulrich, K Sasnauskas… - Medicinal protein …, 2008 - researchgate.net
Food and Drug Administration's (FDA)-approved vaccines against hepatitis B and human
papilloma viruses represent genetically engineered virus-like particles (VLPs) generated in …

[HTML][HTML] Human major histocompatibility complex (MHC) class I molecules with disulfide traps secure disease-related antigenic peptides and exclude competitor …

SM Truscott, X Wang, L Lybarger, WE Biddison… - Journal of Biological …, 2008 - ASBMB
The ongoing discovery of disease-associated epitopes detected by CD8 T cells greatly
facilitates peptide-based vaccine approaches and the construction of multimeric soluble …

Enhancement of cytotoxic T lymphocyte activity by dendritic cells loaded with Tat‐protein transduction domain‐fused hepatitis B virus core antigen

X Chen, Y Yu, Q Pan, Z Tang, J Han… - Acta Biochimica et …, 2008 - Wiley Online Library
The protein transduction domain (PTD) of human immunodeficiency virus‐1‐Tat protein has
a unique potency to penetrate the cellular membranes. To synthesize the sequence of Tat …

[图书][B] Medicinal protein engineering

YE Khudyakov - 2008 - taylorfrancis.com
An All-Inclusive Review of the Achievements and Trends in the Fast-Growing Protein
Engineering Field From humble beginnings like making fire for mere survival, engineering …

[引用][C] 乙型肝炎病毒多表位疫苗的研究进展及现有的常用表位

薛皓, 张颖倩, 薛付忠, 马春红 - 预防医学论坛, 2008